Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack.

NCT04564742 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4017

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myocardial Infarction
Heart Failure

Interventions

DRUG: Dapagliflozin
DRUG: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]